Scientific Alliances Lead

Location: Root D4, CH, 6039To join our Global Medical Affairs team, and located either in US or Switzerland, we are looking for a:
**Scientific Alliances Lead**

The Scientific Alliances Lead is responsible for defining and implementing a structured Global Cooperative Group and Academic Research Center program. This role involves collaborating with the Global Medical Affairs, Pre-Clinical, Clinical and Product Development Teams to develop, align, and facilitate scientific alliances and global networks that support clinical trials and evidence generation. The role requires strategic collaboration with internal and external stakeholders to enhance the planning, implementation, and execution of globally significant evidence generation initiatives. The role requires a robust scientific background, extensive experience in clinical research, and a strong track record in managing Investigator Sponsored Trials (ISTs).

**Your responsibilities**:

- **Program Development**:

- Define and structure a Cooperative Group and Academic Research Center program in collaboration with Global Medical Affairs, Pre-Clinical, Clinical and Product Development Teams
- Establish collaboration agreements to support evidence generation and information exchange.
- Identify, update, and maintain a database of key collaborative research groups worldwide.
- **ISTs Management**:

- Oversee the end-to-end process of ISTs, from proposal evaluation and approval to study execution and results dissemination.
- Serve as the primary point of contact for investigators, providing guidance and support throughout the trial lifecycle.
- Ensure ISTs are conducted in compliance with relevant regulations, guidelines, and company policies.
- **Stakeholder Coordination**:

- Facilitate the establishment of a coordinated global network of internal and external stakeholders.
- Enable efficiencies in the planning, implementation, and execution of supported clinical trials.
- **Regulatory Compliance**:

- Ensure all evidence generation activities comply with relevant regulations, guidelines, and industry standards.
- Maintain up-to-date knowledge of regulatory requirements and changes in the clinical research landscape.
- Develop and implement policies and procedures to ensure compliance and mitigate risks.
- **Representation and Negotiation**:

- Represent Novocure at global cooperative group meetings, scientific meetings, industry conferences, and other professional events.
- Lead or facilitate discussions and negotiations with Cooperative Group leadership and Academic Centers, as required.
- **Process Improvement**:

- Develop master agreements for work with cooperative groups.
- Simplify processes used to collaborate with external researchers

**Your profile**:
Qualifications:

- Advanced degree (PhD, MD, PharmD) in a relevant scientific field.
- Minimum of 8 years of experience in medical affairs, clinical research or a related field within the biotech or pharmaceutical industry.
- Proven track record in managing collaborative research programs and partnerships as well as investigator-initiated trials and other evidence generation initiatives.
- Strong understanding of clinical research methodologies, study design, and data analysis.

Preferred Skills:

- Leadership: Ability to lead and inspire cross-functional teams and external partners.
- Strategic Thinking: Capable of developing and executing long-term strategic plans.
- Collaboration: Strong interpersonal skills to facilitate collaboration among diverse stakeholders.
- Negotiation: Skilled in negotiating agreements and managing complex relationships.
- Communication: Effective communicator with the ability to convey complex information clearly and concisely.

Travel requirements:

- Approx. 40 - 50%

**About Novocure**:
Novocure is a global publicly-traded commercial-stage oncology company developing a profoundly different cancer treatment therapy called tumor treating fields (TTFields) for patients with solid tumors. TTFields therapy is a non-invasive, novel, antimitotic treatment modality which utilizes proprietary technology attempting to slow or reverse tumor progression by inducing tumor cell death. Novocure's commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma (GBM) in the USA, Europe and Israel. Novocure has ongoing or completed clinical trials and is further expanding its efforts into several other solid tumor indications - non-small cell lung cancer, pancreatic cancer, and other types of solid cancers.